Corticotropin-Releasing Factor and Urocortin I Modulate Excitatory Glutamatergic Synaptic Transmission

Journal of Neuroscience

Volumn 24, Issue 16, 2004, Pages 4020-4029

  Liu, Jie ^a   Yu, Baojian ^a   Neugebauer, Volker ^a   Grigoriadis, Dimitri E ^b   Rivier, Jean ^c   Vale, Wylie W ^c   Shinnick Gallagher, Patricia ^a   Gallagher, Joel P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Amygdala; CRF; Glutamatergic synaptic transmission; Lateral septum; Synaptic homeostasis; Urocortin

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ANTALARMIN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BICUCULLINE METHIODIDE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; LIGAND; PEPTIDE HORMONE; PICROTOXIN; RECEPTOR SUBTYPE; TETRODOTOXIN; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; MALE; MOOD DISORDER; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STRESS; SYNAPSE; SYNAPTIC TRANSMISSION;

AMYGDALA; ANIMALS; CELL MEMBRANE; CORTICOTROPIN-RELEASING HORMONE; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HUMANS; LIGANDS; LIMBIC SYSTEM; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEPTAL NUCLEI; SYNAPTIC TRANSMISSION;

EID: 2142814332     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5531-03.2004     Document Type: Article

References (61)

1. Abraham WC, Bear MF (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19:126-130.
2. Aggleton JP (1992) The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley.
3. Aldenhoff J, Gruol DL, Rivier J, Vale W, Siggins GR (1983) Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221:875-877.
4. Alheid GF, Heimer L (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27:1-39.
5. Bakshi VP, Smith-Roe S, Newman SM, Grigoriadis DE, Kalin NH (2002) Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J Neurosci 22:2926-2935.
6. Bale TL, Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557.
7. Bishop GA (2002) Development of a corticotropin-releasing factor-mediated effect on the firing rate of Purkinje cells in the postnatal mouse cerebellum. Exp Neurol 178:165-174.
8. Blank T, Nijholt I, Eckart K, Spiess J (2002) Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci 22:3788-3794.
9. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J (2003) Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 23:700-707.
10. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154:624-629.
11. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
12. Dallman MF (2003) Stress by any other name...? Horm Behav 43:18-20.
13. Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77.
14. Dautzenberg FM, Killpatrick GJ, Hauger RL, Moreau J-L (2001) Molecular biology of the CRH receptors-in the mood. Peptides 22:753-760.
15. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety in the stress response? Brain Res Rev 15:71-100.
16. Eaves M, Thatcher-Britton K, Rivier J, Vale W, Koob G (1985) Effects of corticotropin-releasing factor on locomotor activity in hypophysectomized rats. Peptides 6:923-926.
17. Fox EA, Gruol DL (1993) Corticotropin-releasing factor suppresses the afterhyperpolarization in cerebellar Purkinje neurons. Neurosci Lett 149:103-107.
18. Grammatopoulos DK, Randeva H, Levine M, Kanellopoulou K, Hillhouse E (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 76:509-519.
19. Harrigan EA, Magnuson DJ, Thunstedt GM, Gray TS (1994) Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus. Brain Res Bull 33:529 -534.
20. Hauger RL, Grigoriadis DE, Dallman M, Plotsky PM, Vale WW, Dautzenberg FM (2003) International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 55:21-26.
21. Hsu SY, Hsueh AJW (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the corticotropin-releasing hormone receptor. Nat Med 7:605-606.
22. Jakab RL, Leranth C (1995) Septum. In: The rat nervous system (Paxinos G, ed), pp 405-442. San Diego: Academic.
23. Katz B, Miledi R (1968) The role of calcium in neuromascular facilitation. J Physiol 195:481-492.
24. King JS, Bishop GA (2002) The distribution and cellular localization of CRF-R1 in the vermis of the postnatal mouse cerebellum. Exp Neurol 178:175-185.
25. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin HA, Miczek KA, Britton KT (1993) The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found Symp 172:277-295.
26. Lewis, K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575.
27. Li C, Vaughan J, Sawchenko PE, Vale WW (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22:991-1001.
28. Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJ, Davis M (1992) Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin releasing factor on the acoustic startle reflex. J Neurosci 12:2313-2320.
29. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A (1995) Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239.
30. Liebsch G, Landgraf R, Engelmann M, Lorscher P, Holsboer F (1999) Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 33:153-163.
31. Manabe T, Wyllie DJA, Perkel DJ, Nicoll RA (1993) Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J Neurophysiol 70:1451-1459.
32. McCarthy JR, Heinrichs SC, Grigoriadis DE (1999) Recent advances with the CRF1 receptor design of small molecule inhibitors, receptor sybtypes and clinical implications. Curr Pharm Des 5:289-315.
33. McEwen BS, Wingfield JC (2003) The concept of allostasis in biology and biomedicine. Horm Behav 43:2-15.
34. Miyata M, Okada D, Hashimoto K, Kano M, Ito M (1999) Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression. Neuron 22:763-775.
35. Müller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MS, Droste SK, Kuhn R, Reul JM, Holsboer F, Wurst W (2003) Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6:1100-1107.
36. Neugebauer V, Zinebi F, Russell R, Gallagher JP, Shinnick-Gallagher P (2000) Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala. J Neurophysiol 84:759-770.
37. Numan R (2000) The behavioral neuroscience of the septal region. New York: Springer.
38. Owens MJ, Nemeroff CB (1993) The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp 172:296-308.
39. Radulovic J, Ruhmann A, Liepold T, Spiess J (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differetial roles of CRF receptors 1 and 2. J Neurosci 19:5016-5025.
40. Rainnie DG, Fernhout BJH, Shinnick-Gallagher P (1992) Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. J Pharmacol Exp Ther 263:846-858.
41. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848.
42. Rivier C, Vale W (1987) Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 422:403-406.
43. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi J-C, Waser B, Koerber SC, Martinez V, Wang L, Tache Y, Vale W (2002) Potent and long-acting corticotropin releasing factor (CRF) receptor 2 peptide competitive antagonists. J Med Chem 45:4737-4747.
44. Rivier JE, Gulyas JD, Kirby K, Kunitake K, Donaldson C, Vaughn J, Perrin S, Koerber S, Martinez V, Tache Y, Rivier C, Vale W (2001) Receptor-selective corticotropin-releasing factor analogs. Soc Neurosci Abstr 31:413.17.
45. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 99:13908-13913.
46. Rothman RB, Vu N, Xu H, Baumann MH, Lu YF (2002) Endogenous corticotropin releasing factor regulates adrenergic and opioid receptors. Peptides 23:2177-2180.
47. Sauvage M, Steckler T (2001) Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei: potential implication for arousal and attention. Neuroscience 104:643-652.
48. Shinnick-Gallagher P, Pitkanen A, Shekhar A, Cahill L (2003) The amygdala in brain function: basic and clinical approaches. Ann NY Acad Sci 985.
49. Smith BN, Dudek FE (1994) Age-related epileptogenic effects of corticotropin-releasing hormone in the isolated CA1 region of rat hippocampal slices. J Neurophysiol 72:2328-2333.
50. Steckler T, Holsboer F (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46:1480-1508.
51. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
52. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A (2003) Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39:401-407.
53. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397.
54. Valentino RJ (1989) Corticotropin-releasing factor: putative neurotransmitter in the noradrenergic nucleus locus ceruleus. Psychopharmacol Bull 25:306-311.
55. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292.
56. Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS (2000) Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 85:4138-4145.
57. Wang HL, Tsai LY, Lee EHY (2000) Corticotropin-releasing factor produces a protein synthesis-dependent long-lasting potentiation in dentate gyrus neurons. J Neurophysiol 83:343-349.
58. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotripin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750.
59. Yadin E, Thomas E, Grishkat HL, Strickland CE (1993) The role of the lateral septum in anxiolysis. Physiol Behav 53:1077-1083.
60. Yu B, Shinnick-Gallagher P (1998) Corticotropin-releasing factor increases dihydropyridine- and neurotoxin-resistant calcium currents in neurons of the central amygdala. J Pharmacol Exp Ther 284:170-179.
61. A synaptic receptors. Neuroscience 113:1-10.